News

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.
Tariffs could have deep impacts on costs for prescription drugs: What to know Among other ramifications, tariffs would exasperate medication shortages because many cheaper generic drugs are ...
President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tar… ...